No abstract available
Keywords:
anti-cancer drugs; biomarkers; cancer; genetic variance; heart failure; population studies; risk factors.
Grants and funding
This study was supported by grants Fondation de France (R20085MM), and French government managed by Agence Nationale de la Recherche (ANR-16-ECVD-0005-01) (CN).